We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Cervical Occlusion During Intrauterine Insemination (IUI)

This study has been terminated.
(Randomization flawed. Results were poor in the innovative catheter group)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00951171
First Posted: August 4, 2009
Last Update Posted: August 28, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Andrew Blazar, M.D., Women and Infants Hospital of Rhode Island
  Purpose

Study Hypothesis: There is a difference in pregnancy rates between intrauterine insemination (IUI) in cycles performed with cervical occlusion by a balloon catheter designed for sonohysterograms as compared to those performed with a standard inseminator.

The investigators will compare pregnancy rates in patients undergoing routine IUI either with balloon occlusion or with standard insemination. The patients will receive the standard clinical care per the investigators' office guidelines, except they will be randomized to insemination with either of two catheters.


Condition Intervention Phase
Infertility Procedure: Intrauterine Insemination Procedure: IUI with the standard inseminator Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of the Effect of Cervical Occlusion During Infertility Treatment by Intrauterine Insemination

Resource links provided by NLM:


Further study details as provided by Andrew Blazar, M.D., Women and Infants Hospital of Rhode Island:

Primary Outcome Measures:
  • Clinical Pregnancy [ Time Frame: 1 month ]
    positive beta HCG test


Secondary Outcome Measures:
  • Live Birth [ Time Frame: 9 months ]
  • Positive Pregnancy Test [ Time Frame: 14 days ]

Enrollment: 93
Study Start Date: February 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cervical occulsion
Insemination Eliptosphere catheter filled with 1cc of air for 15 minutes. H/S Eliptosphere by Copper surgical (U.S. Patent No. 5,624,399)
Procedure: Intrauterine Insemination
The intervention arm will undergo temporary (15 minutes) cervical occlusion with the eliptosphere intracervical catheter. This catheter is typically used to perform saline infusion ultrasounds to image the uterine cavity in our practice.
Other Name: H/SH
Active Comparator: Standard IUI
Insemination with TOmcat catheter
Procedure: IUI with the standard inseminator
The control arm will undergo insemination with the standard inseminator (TOmcat catheter).

Detailed Description:
An open speculum will be used and patients will undergo insemination with their partners sperm (same quantity in both arms). If randomized to treatment arm a balloon catheter will be filled with 1cc of air prior to insemination. The speculum will be removed immediately and the catheter will be left in for 15 minutes and then removed. Pregnancy outcomes will be recorded in both groups.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All patients undergoing IUI for unexplained infertility in our office: Center for Reproduction and Infertility (Providence, RI)

Exclusion Criteria:

  • "Abnormal" Semenalysis TMC < 5 million
  • Blocked Fallopian tubes
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00951171


Locations
United States, Rhode Island
Center for Reproduction and Infertility
Providence, Rhode Island, United States, 02905
Sponsors and Collaborators
Women and Infants Hospital of Rhode Island
Investigators
Principal Investigator: Andrew Blazar, MD Women & Infants Hospital
  More Information

Responsible Party: Andrew Blazar, M.D., Prinicpal Investigator, Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier: NCT00951171     History of Changes
Other Study ID Numbers: CO_IUI
First Submitted: July 31, 2009
First Posted: August 4, 2009
Results First Submitted: July 10, 2012
Results First Posted: August 28, 2012
Last Update Posted: August 28, 2012
Last Verified: August 2012

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female